Alerts will be sent to your verified email
Verify Email
SENORES
|
Senores Pharmaceutic
|
Ajanta Pharma
|
Alembic Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceuticals
|
|||
|
Number of ANDA's Approved
|
108.0 . | n/a | n/a |
|
R&D as a % of Total Sales
|
16.92 % | 5.0 % | 11.0 % |
|
Financials
|
|||
|
5 yr Average ROE
|
11.02 % | 21.93 % | 12.89 % |
|
5yr average Equity Multiplier
|
2.25 | 1.33 | 1.39 |
|
5yr Average Asset Turnover Ratio
|
0.3 | 0.86 | 0.86 |
|
5yr Avg Net Profit Margin
|
15.05 % | 19.12 % | 11.15 % |
|
Price to Book
|
6.26 | 8.77 | 2.67 |
|
P/E
|
50.65 | 37.6 | 22.47 |
|
5yr Avg Cash Conversion Cycle
|
-30.87 Days | -104.16 Days | 9.46 Days |
|
Inventory Days
|
46.48 Days | 45.5 Days | 99.1 Days |
|
Days Receivable
|
108.09 Days | 49.07 Days | 66.32 Days |
|
Days Payable
|
255.02 Days | 180.12 Days | 164.9 Days |
|
5yr Average Interest Coverage Ratio
|
4.44 | 103.83 | 30.59 |
|
5yr Avg ROCE
|
10.25 % | 28.04 % | 15.26 % |
|
5yr Avg Operating Profit Margin
|
22.88 % | 25.85 % | 17.29 % |
|
5 yr average Debt to Equity
|
0.83 | 0.01 | 0.14 |
|
5yr CAGR Net Profit
|
126.15 % | 8.18 % | -12.64 % |
|
5yr Average Return on Assets
|
4.54 % | 16.5 % | 9.32 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
45.82 % | 66.25 % | 69.74 % |
|
Share Pledged by Promoters
|
1.9 % | 17.94 % | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.06 % | 0.14 % | 0.13 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
-0.55 % | 1.45 % | 1.71 % |
|
Senores Pharmaceutic
|
Ajanta Pharma
|
Alembic Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|